全文获取类型
收费全文 | 67743篇 |
免费 | 5281篇 |
国内免费 | 1644篇 |
专业分类
耳鼻咽喉 | 783篇 |
儿科学 | 1056篇 |
妇产科学 | 1291篇 |
基础医学 | 10011篇 |
口腔科学 | 1780篇 |
临床医学 | 5850篇 |
内科学 | 13584篇 |
皮肤病学 | 1286篇 |
神经病学 | 5384篇 |
特种医学 | 2153篇 |
外国民族医学 | 6篇 |
外科学 | 9450篇 |
综合类 | 4156篇 |
现状与发展 | 1篇 |
一般理论 | 19篇 |
预防医学 | 4420篇 |
眼科学 | 1809篇 |
药学 | 5612篇 |
中国医学 | 766篇 |
肿瘤学 | 5251篇 |
出版年
2023年 | 283篇 |
2022年 | 450篇 |
2021年 | 883篇 |
2020年 | 530篇 |
2019年 | 939篇 |
2018年 | 1471篇 |
2017年 | 1149篇 |
2016年 | 1122篇 |
2015年 | 1280篇 |
2014年 | 1771篇 |
2013年 | 2232篇 |
2012年 | 3284篇 |
2011年 | 3222篇 |
2010年 | 1881篇 |
2009年 | 1821篇 |
2008年 | 2896篇 |
2007年 | 3135篇 |
2006年 | 2932篇 |
2005年 | 2573篇 |
2004年 | 2412篇 |
2003年 | 2241篇 |
2002年 | 2148篇 |
2001年 | 4734篇 |
2000年 | 4638篇 |
1999年 | 4008篇 |
1998年 | 1555篇 |
1997年 | 1130篇 |
1996年 | 706篇 |
1995年 | 600篇 |
1994年 | 535篇 |
1993年 | 507篇 |
1992年 | 2011篇 |
1991年 | 1728篇 |
1990年 | 1572篇 |
1989年 | 1545篇 |
1988年 | 1339篇 |
1987年 | 1233篇 |
1986年 | 1124篇 |
1985年 | 963篇 |
1984年 | 673篇 |
1983年 | 550篇 |
1982年 | 340篇 |
1981年 | 282篇 |
1980年 | 235篇 |
1979年 | 314篇 |
1978年 | 129篇 |
1976年 | 106篇 |
1975年 | 98篇 |
1974年 | 109篇 |
1973年 | 117篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
43.
44.
X J Zhang K R Kunkel F Jahoor R R Wolfe 《JPEN. Journal of parenteral and enteral nutrition》1991,15(4):394-399
We have investigated the role of basal insulin concentration on leucine kinetics (determined by means of 1-[13C]leucine) and energy metabolism (determined by indirect calorimetry) in eight septic patients by reducing insulin (and glucagon) secretion by somatostatin infusion. Basal glucagon concentration was elevated (744 +/- 381 pg/mL), and insulin concentration was normal (10 +/- 4 microU/mL). Basal resting energy expenditure (REE) was 151 +/- 8% that of predicted basal energy expenditure, and leucine appearance (Ra), oxidation, and nonoxidative disposal rates were all elevated above the normal ranges. Somatostatin infusion reduced insulin concentration by 52% and glucagon concentration by 64%. This resulted in a significant increase in the rate of leucine oxidation from 0.96 +/- 0.08 to 1.18 +/- 0.14 mumol/kg/min (p less than 0.01), and nonoxidative leucine disposal decreased from 2.95 +/- 0.18 to 2.67 +/- 0.17 mumol/kg/min (p less than 0.01). Somatostatin infusion also caused significant increases in REE and fat oxidation from 1310 +/- 100 to 1505 +/- 128 kcal/m2/day (p less than 0.05) and from 1.72 +/- 0.24 to 2.41 +/- 0.41 mg/kg/min, respectively, and a slight decrease of carbohydrate oxidation from 1.51 +/- 0.49 to 1.31 +/- 0.49 mg/kg/min. These metabolic responses can be attributed to the reduction in insulin concentration, because they are in the opposite direction of changes that would occur as a consequence of a reduction in glucagon concentration. We conclude that the basal insulin plays an important role in attenuating net protein loss and energy expenditure. 相似文献
45.
46.
47.
Abstract: A pulsatile impeller assist heart and a total heart were tested as a chronic left ventricular assist device in 5 calves and an acute biventricular assist device in 4 pigs respectively, to evaluate their blood compatibility. During the left ventricular assist experiments, the indicators for hemolysis, thrombogenesis, renal dysfunction, and hepatic dysfunction were measured preoperatively, at the beginning of the pumping, 6 h postoperatively, and every following day. The results demonstrated that the impeller assist heart causes no severe blood damage nor organ dysfunction in the experiments lasting up to 11 days. In biventricular assist experiments, the number of red blood cells, white blood cells, platelets, and the he-matocrit, hemoglobin, free hemoglobin, and lactate dehy-drogenase levels were tested preoperatively at the beginning of the pumping and every 2 h postoperatively. The data remained in acceptable ranges during experiments lasting 6 h. It is confirmed that the authors' impeller assist heart and total heart have the advantages of simplicity, implantability, and pulsatility with good blood compatibility. 相似文献
48.
49.
Calcitonin gene-related peptide (CGRP) causes vasorelaxation in rat aorta involving endothelium/nitric oxide (NO)-dependent elevations of both cAMP and cGMP levels. When endothelium is removed, preincubation with exogenous NO uncovers and potentiates direct (endothelium-independent) cAMP elevations and vasorelaxations caused by CGRP. This enhancing effect of NO potentially involves elevation of cGMP and inhibition of Type III (cGMPinhibitable) phosphodiesterase, causing accumulation of cAMP. However, NO may have other actions. The aim of the present study was to determine if brain natriuretic peptide (BNP), which elevates cGMP levels independent of NO, could enhance cAMP accumulations and vasorelaxations induced by CGRP in rat aortic rings denuded of endothelium. When added separately, neither CGRP (100 nM) nor BNP (10 nM) altered cAMP levels. When added in combination, CGRP (100 nM) and BNP (10 nM) significantly elevated cAMP levels (from control of 0.95 ± 0.08 to 1.53 ± 0.09 pmol/mg protein) at 2 min. BNP (10 nM) elevated cGMP levels 10-fold at 2 min and this response was not altered by co-administration of CGRP (100 nM).Pretreatment with BNP at concentrations as low as 1 nM in endothelium-denuded aortic rings greatly enhanced the direct vasorelaxant effects of CGRP (100 nM) (from control of 0% to 57.6 ± 6.8% relaxation of phenylephrineprecontractions). Our findings indicate that BNP enhances direct (endothelium-independent) cAMP elevations and vasorelaxations caused by CGRP in rat aorta, thus supporting the concept that cGMP inhibits cAMP metabolism and enhances CGRP-induced responses in aortic smooth muscle cells. 相似文献
50.
M P Johnson X M Huang R Oberlender J F Nash D E Nichols 《European journal of pharmacology》1990,191(1):1-10
The present set of experiments was designed to examine the effects of extension of the alpha-methyl of p-chloroamphetamine (PCA) to an alpha-ethyl. Therefore, the alpha-ethyl homologue of PCA, 1-(4-chlorophenyl)-2-aminobutane (CAB), was compared to PCA in a number of pharmacological assays. CAB was 2-fold less potent than PCA at inhibiting synaptosomal uptake of [3H]5-hydroxytryptamine ([3H]5-HT), and 5-fold less potent at inhibiting uptake of [3H]dopamine ([3H]DA). In drug discrimination assays, CAB was approximately 3-fold less potent than PCA in animals trained to discriminate 3,4-methylenedioxymethamphetamine (MDMA) or its alpha-ethyl homologue, S-(+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine (S-(+)-MBDB), from saline. Monitoring with in vivo microdialysis, 10 mg/kg of PCA caused a large increase in extracellular DA and a significant decrease in 3,4-dihydroxyphenylacetic acid (DOPAC) in the striatum. In contrast, 11 mg/kg CAB caused no increase and 22 mg/kg CAB caused only a slight increase in extracellular DA. Both doses of CAB caused a decrease in extracellular DOPAC. The potential 5-HT neurotoxicity of CAB was examined by measuring monoamine and metabolite levels and [3H]paroxetine binding at one week following acute doses. A 10 mg/kg dose of PCA caused an 80% decrease in cortical and hippocampal serotonergic markers, while an equimolar dose of CAB decreased only hippocampal 5-HT and 5-hydroxyindoleacetic acid (5-HIAA) levels. However, 22 mg/kg of CAB produced a 20-40% decrease in all serotonergic markers. Thus, extension of the alpha-alkyl significantly decreases the dopaminergic effects of PCA. The similar decrease in relative 5-HT neurotoxicity and the decreased ability to alter dopaminergic systems in vivo and in vitro supports the involvement of DA in the neurotoxicity of PCA. 相似文献